Holdings (Monthly)
Guide ↗
iShares Genomics Immunology and Healthcare ETF
· iShares Trust| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 066922519 | Apr 2024 | 23,618,144 | $23.6M | 16.55% | STIV |
| 2 | MODERNA, INC. | 60770K107 | Apr 2024 | 190,514 | $8.4M | 5.88% | EC |
| 3 | Bayer Aktiengesellschaft | N/A | Jan 2026 | 136,034 | $7.2M | 5.04% | EC |
| 4 | Revolution Medicines Inc | 76155X100 | Apr 2024 | 66,264 | $6.4M | 4.50% | EC |
| 5 | Takeda Pharmaceutical Company Limited | N/A | Jan 2026 | 185,800 | $6.3M | 4.43% | EC |
| 6 | BioNTech SE | 09075V102 | Apr 2024 | 54,828 | $6.2M | 4.37% | — |
| 7 | Roche Holding AG | N/A | Jan 2026 | 13,651 | $6.2M | 4.35% | EC |
| 8 | IPSEN SA | N/A | Jan 2026 | 37,167 | $6.1M | 4.25% | EC |
| 9 | MERCK & CO., INC. | 58933Y105 | Apr 2024 | 52,921 | $5.8M | 4.09% | EC |
| 10 | GSK PLC | N/A | Jan 2026 | 219,125 | $5.7M | 3.97% | EC |
| 11 | REGENERON PHARMACEUTICALS, INC. | 75886F107 | Apr 2024 | 7,346 | $5.4M | 3.81% | EC |
| 12 | VERTEX PHARMACEUTICALS INCORPORATED | 92532F100 | Jan 2026 | 11,586 | $5.4M | 3.81% | EC |
| 13 | GENMAB A/S | N/A | Jan 2026 | 16,654 | $5.4M | 3.80% | EC |
| 14 | INCYTE CORPORATION | 45337C102 | Apr 2024 | 51,475 | $5.2M | 3.61% | EC |
| 15 | SANOFI SA | N/A | Jan 2026 | 53,301 | $5.0M | 3.52% | EC |
| 16 | EXELIXIS, INC. | 30161Q104 | Apr 2024 | 118,964 | $4.9M | 3.45% | EC |
| 17 | Arcellx Inc | 03940C100 | Apr 2024 | 66,953 | $4.6M | 3.20% | EC |
| 18 | IDEAYA Biosciences Inc | 45166A102 | Jan 2026 | 129,735 | $4.2M | 2.92% | EC |
| 19 | CARIS LIFE SCIENCES, INC. | 142152107 | Jan 2026 | 178,559 | $4.1M | 2.90% | EC |
| 20 | Twist Bioscience Corp | 90184D100 | Apr 2024 | 90,235 | $3.7M | 2.60% | EC |
| 21 | Immunitybio Inc | 45256X103 | Apr 2024 | 513,330 | $3.2M | 2.25% | EC |
| 22 | ONO PHARMACEUTICAL CO., LTD. | N/A | Jan 2026 | 185,600 | $2.8M | 1.94% | EC |
| 23 | ARCUS BIOSCIENCES, INC. | 03969F109 | Apr 2024 | 115,988 | $2.4M | 1.71% | EC |
| 24 | CRISPR Therapeutics AG | H17182108 | Jan 2026 | 48,041 | $2.4M | 1.68% | EC |
| 25 | NOVAVAX, INC. | 670002401 | Apr 2024 | 229,390 | $2.0M | 1.42% | EC |
| 26 | Nuvation Bio Inc | 67080N101 | Jan 2026 | 370,402 | $1.9M | 1.36% | EC |
| 27 | Corvus Pharmaceuticals Inc | 221015100 | Jan 2026 | 88,900 | $1.8M | 1.29% | EC |
| 28 | Iovance Biotherapeutics Inc | 462260100 | Apr 2024 | 514,666 | $1.3M | 0.92% | EC |
| 29 | ABCELLERA BIOLOGICS INC. | 00288U106 | Apr 2024 | 357,878 | $1.3M | 0.91% | EC |
| 30 | GenFleet Therapeutics (Shanghai) Inc | Y2S2YD109 | Jan 2026 | 300,800 | $1.2M | 0.83% | EC |
| 31 | Janux Therapeutics Inc | 47103J105 | Jan 2026 | 83,115 | $1.1M | 0.80% | EC |
| 32 | CytomX Therapeutics Inc | 23284F105 | Jan 2026 | 198,426 | $1.1M | 0.79% | EC |
| 33 | Vir Biotechnology Inc | 92764N102 | Apr 2024 | 144,941 | $1.1M | 0.76% | EC |
| 34 | Kura Oncology Inc | 50127T109 | Jan 2026 | 130,406 | $1.1M | 0.74% | EC |
| 35 | VALNEVA SE | N/A | Jan 2026 | 223,456 | $1.0M | 0.72% | EC |
| 36 | AbClon Inc. | Y0R0KQ104 | Jan 2026 | 23,520 | $1.0M | 0.72% | EC |
| 37 | RIGEL PHARMACEUTICALS, INC. | 766559702 | Jan 2026 | 27,421 | $956K | 0.67% | EC |
| 38 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | 69404D108 | Jan 2026 | 417,556 | $944K | 0.66% | EC |
| 39 | Sunshine Lake Pharma Co Ltd | Y8243F109 | Jan 2026 | 165,900 | $904K | 0.63% | EC |
| 40 | Alvotech SA | L01800108 | Jan 2026 | 163,916 | $880K | 0.62% | EC |
| 41 | Personalis Inc | 71535D106 | Jan 2026 | 82,376 | $772K | 0.54% | EC |
| 42 | INTELLIA THERAPEUTICS, INC. | 45826J105 | Apr 2024 | 57,945 | $762K | 0.53% | EC |
| 43 | Ocugen Inc | 67577C105 | Jan 2026 | 477,437 | $692K | 0.48% | EC |
| 44 | VERASTEM, INC. | 92337C203 | Jan 2026 | 100,510 | $613K | 0.43% | EC |
| 45 | Ginkgo Bioworks Holdings Inc | 37611X209 | Jan 2026 | 65,516 | $588K | 0.41% | EC |
| 46 | Shanghai Henlius Biotech Inc | N/A | Jan 2026 | 73,000 | $536K | 0.38% | EC |
| 47 | Design Therapeutics Inc | 25056L103 | Jan 2026 | 48,520 | $495K | 0.35% | EC |
| 48 | Xencor Inc | 98401F105 | Apr 2024 | 35,366 | $428K | 0.30% | EC |
| 49 | Guangzhou Innogen Pharmaceutical Group Co Ltd | Y293B9102 | Jan 2026 | 104,600 | $399K | 0.28% | EC |
| 50 | Prime Medicine Inc | 74168J101 | Jan 2026 | 49,464 | $188K | 0.13% | EC |
| 51 | Mereo BioPharma Group PLC | 589492107 | Jan 2026 | 213,432 | $94K | 0.07% | — |
| 52 | BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares | 066922477 | Apr 2024 | 77,543 | $78K | 0.05% | STIV |
| 53 | GREAT BRITISH POUND | N/A | Jan 2026 | 33,563 | $46K | 0.03% | — |
| 54 | EURO | N/A | Jan 2026 | 24,193 | $29K | 0.02% | — |
| 55 | JAPANESE YEN | N/A | Jan 2026 | 2,771,895 | $18K | 0.01% | — |
| 56 | DANISH KRONER | N/A | Jan 2026 | 77,905 | $12K | 0.01% | — |
| 57 | SWISS FRANC | N/A | Jan 2026 | 9,326 | $12K | 0.01% | — |
| 58 | KOREAN WON | N/A | Jan 2026 | 249,354 | $173 | 0.00% | — |
| 59 | HONG KONG DOLLAR | N/A | Jan 2026 | 1,308 | $167 | 0.00% | — |
| 60 | NEW TAIWAN DOLLAR | N/A | Jan 2026 | 5,229 | $166 | 0.00% | — |
| 61 | XAV HEALTH CARE MAR26 | 1XAVH26 | Jan 2026 | 1 | $86 | 0.00% | DE |
| 62 | OMNIAB INC | 68218J202 | Apr 2024 | 19,498 | $0 | 0.00% | EC |
| 63 | OMNIAB INC | 68218J301 | Apr 2024 | 19,498 | $0 | 0.00% | EC |